# Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

> clinical trial · VERIFIED · 2026-07-28

Status: RECRUITING · Sponsor: RAPT Therapeutics, Inc. · Condition: Ig-E Mediated Food Allergy

- Company: RAPT Therapeutics, Inc.
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT07220811

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.